 Thao Vu
Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metabolomics | 6 | 2024 | 727 | 1.580 |
Why?
| | Magnetic Resonance Spectroscopy | 4 | 2022 | 630 | 1.150 |
Why?
| | Genome-Wide Association Study | 3 | 2025 | 1406 | 0.730 |
Why?
| | Tumor Microenvironment | 2 | 2023 | 732 | 0.710 |
Why?
| | Algorithms | 5 | 2025 | 1837 | 0.580 |
Why?
| | Magnetic Resonance Imaging | 2 | 2022 | 3863 | 0.540 |
Why?
| | Principal Component Analysis | 3 | 2023 | 197 | 0.520 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2025 | 2145 | 0.510 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2019 | 346 | 0.510 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 2 | 2023 | 1180 | 0.490 |
Why?
| | Data Interpretation, Statistical | 1 | 2018 | 372 | 0.490 |
Why?
| | Mass Spectrometry | 1 | 2019 | 750 | 0.470 |
Why?
| | Lung Neoplasms | 2 | 2023 | 2637 | 0.360 |
Why?
| | Computational Biology | 3 | 2025 | 680 | 0.340 |
Why?
| | Software | 2 | 2025 | 690 | 0.300 |
Why?
| | Discriminant Analysis | 2 | 2019 | 36 | 0.290 |
Why?
| | Computer Simulation | 2 | 2024 | 1025 | 0.280 |
Why?
| | Gene Expression Profiling | 2 | 2025 | 1782 | 0.220 |
Why?
| | 2S Albumins, Plant | 1 | 2025 | 31 | 0.220 |
Why?
| | Antigens, Plant | 1 | 2025 | 55 | 0.220 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2025 | 178 | 0.210 |
Why?
| | Kynurenine | 1 | 2024 | 114 | 0.200 |
Why?
| | Entropy | 1 | 2023 | 45 | 0.200 |
Why?
| | Herpes Zoster Vaccine | 1 | 2025 | 154 | 0.200 |
Why?
| | Immunoglobulin E | 1 | 2025 | 315 | 0.200 |
Why?
| | Tryptophan | 1 | 2024 | 181 | 0.200 |
Why?
| | Proton Magnetic Resonance Spectroscopy | 1 | 2022 | 20 | 0.190 |
Why?
| | Epitopes | 1 | 2025 | 485 | 0.190 |
Why?
| | Transforming Growth Factor beta | 1 | 2025 | 479 | 0.190 |
Why?
| | Monocytes | 1 | 2025 | 538 | 0.190 |
Why?
| | Sequence Analysis, RNA | 1 | 2025 | 442 | 0.190 |
Why?
| | Sample Size | 1 | 2023 | 123 | 0.190 |
Why?
| | Genomics | 2 | 2025 | 834 | 0.180 |
Why?
| | Herpesvirus 3, Human | 1 | 2025 | 336 | 0.180 |
Why?
| | Artifacts | 1 | 2022 | 139 | 0.180 |
Why?
| | Herpes Zoster | 1 | 2025 | 315 | 0.180 |
Why?
| | Single-Cell Analysis | 1 | 2025 | 358 | 0.180 |
Why?
| | Machine Learning | 2 | 2025 | 585 | 0.180 |
Why?
| | Metabolome | 1 | 2024 | 384 | 0.160 |
Why?
| | Proportional Hazards Models | 1 | 2023 | 1325 | 0.150 |
Why?
| | Support Vector Machine | 1 | 2019 | 36 | 0.150 |
Why?
| | Least-Squares Analysis | 1 | 2019 | 76 | 0.150 |
Why?
| | Signal-To-Noise Ratio | 1 | 2018 | 73 | 0.140 |
Why?
| | Immunohistochemistry | 1 | 2022 | 1716 | 0.140 |
Why?
| | Proteomics | 1 | 2024 | 1195 | 0.130 |
Why?
| | Smoking | 1 | 2024 | 1472 | 0.130 |
Why?
| | Humans | 14 | 2025 | 144759 | 0.130 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2024 | 920 | 0.120 |
Why?
| | Clinical Competence | 1 | 2025 | 1244 | 0.120 |
Why?
| | Pediatrics | 1 | 2025 | 1114 | 0.120 |
Why?
| | Multivariate Analysis | 1 | 2019 | 1539 | 0.120 |
Why?
| | Reproducibility of Results | 2 | 2022 | 3409 | 0.110 |
Why?
| | Internship and Residency | 1 | 2025 | 1257 | 0.100 |
Why?
| | Proteome | 1 | 2018 | 518 | 0.100 |
Why?
| | Quantitative Trait Loci | 2 | 2025 | 374 | 0.090 |
Why?
| | HIV Infections | 1 | 2025 | 3154 | 0.080 |
Why?
| | Neoplasms | 1 | 2025 | 2875 | 0.080 |
Why?
| | Sex Characteristics | 2 | 2024 | 790 | 0.070 |
Why?
| | Sex Factors | 2 | 2024 | 2112 | 0.070 |
Why?
| | Phenotype | 2 | 2025 | 3162 | 0.060 |
Why?
| | Vietnam | 1 | 2025 | 30 | 0.060 |
Why?
| | Vaccines, Synthetic | 1 | 2025 | 138 | 0.060 |
Why?
| | Epitope Mapping | 1 | 2025 | 61 | 0.060 |
Why?
| | Aged | 4 | 2025 | 25913 | 0.050 |
Why?
| | Down-Regulation | 1 | 2025 | 627 | 0.050 |
Why?
| | Peanut Hypersensitivity | 1 | 2025 | 143 | 0.050 |
Why?
| | Middle Aged | 4 | 2025 | 35875 | 0.050 |
Why?
| | Killer Cells, Natural | 1 | 2025 | 467 | 0.050 |
Why?
| | Regression Analysis | 1 | 2025 | 1003 | 0.050 |
Why?
| | Carbon Isotopes | 1 | 2022 | 144 | 0.050 |
Why?
| | Models, Genetic | 1 | 2025 | 536 | 0.050 |
Why?
| | Dendritic Cells | 1 | 2025 | 499 | 0.040 |
Why?
| | Gene Regulatory Networks | 1 | 2024 | 318 | 0.040 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2025 | 549 | 0.040 |
Why?
| | Analysis of Variance | 1 | 2024 | 1306 | 0.040 |
Why?
| | Amino Acid Sequence | 1 | 2025 | 2155 | 0.040 |
Why?
| | Male | 5 | 2025 | 72315 | 0.040 |
Why?
| | Education, Medical, Graduate | 1 | 2025 | 557 | 0.040 |
Why?
| | Female | 5 | 2025 | 78271 | 0.040 |
Why?
| | Genotype | 1 | 2025 | 1833 | 0.040 |
Why?
| | Immunity, Innate | 1 | 2025 | 846 | 0.040 |
Why?
| | Genetic Variation | 1 | 2024 | 983 | 0.040 |
Why?
| | Peptides | 1 | 2025 | 995 | 0.040 |
Why?
| | Protein Binding | 1 | 2025 | 2273 | 0.040 |
Why?
| | Stroke | 1 | 2024 | 1256 | 0.030 |
Why?
| | Cohort Studies | 1 | 2024 | 5960 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2024 | 8265 | 0.020 |
Why?
| | Infant | 1 | 2025 | 10034 | 0.020 |
Why?
| | Child, Preschool | 1 | 2025 | 11787 | 0.020 |
Why?
| | Young Adult | 1 | 2025 | 14105 | 0.020 |
Why?
| | Adolescent | 1 | 2025 | 22428 | 0.010 |
Why?
| | Child | 1 | 2025 | 22633 | 0.010 |
Why?
| | Adult | 1 | 2025 | 40449 | 0.010 |
Why?
|
|
Vu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|